United States · 
Who invested in Capsida Biotherapeutics?
Capsida Biotherapeutics's investors include Versant Ventures and AbbVie.
United States · Venture startup
Who invested in Capsida Biotherapeutics
Funding summaryUpdated 26 Oct 2026
Undisclosedraised across 1 round since 2023, from 1 source
- Latest round
- VentureFeb 2023
- Investors
- 2
The rounds
- Feb 2023
Founders and team
From Capsida Biotherapeutics's own website: 2 on the team.
- Amar DuvvurChief Operating Officer & Chief Financial Officer
- Mina KimExecutive Chair
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Capsida Biotherapeutics
How much has Capsida Biotherapeutics raised?
Capsida Biotherapeutics has raised 1 round since 2023, none with a disclosed amount.
When did Capsida Biotherapeutics last raise?
Capsida Biotherapeutics's most recent round was a Venture in Feb 2023.
Who backed Capsida Biotherapeutics first?
Capsida Biotherapeutics's first round on record, in Feb 2023, was backed by Versant Ventures and AbbVie.
What stage is Capsida Biotherapeutics at?
Capsida Biotherapeutics's latest named round is a Venture, in Feb 2023.
Where is Capsida Biotherapeutics based?
Capsida Biotherapeutics is based in the United States.
Companies like Capsida Biotherapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.